Finance

Lists
RIGL:NASDAQ
Rigel Pharmaceuticals Inc
၄၇.၁၅ US$
+၀.၃၈%
(+၀.၁၈) 1D
၄၇.၁၅ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၂, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RIGL...
Open
၄၇.၆၆ US$
High
၄၈.၀၀ US$
Low
၄၆.၄၅ US$
Mkt. cap
၈၈.၀၈ ကုဋေ
Avg. vol.
၂.၅၇ သိန်း
Volume
၁.၈၆ သိန်း
P/E ratio
၂.၉၄
52-wk high
၅၂.၀၆ US$
52-wk low
၂၄.၉၅ US$
EPS
၁၆.၀၄ US$
Beta
၁.၁၉
Shares outstanding
၁.၈၇ ကုဋေ
No. of employees
၁၇၃
Open
၄၇.၆၆ US$
High
၄၈.၀၀ US$
Low
၄၆.၄၅ US$
Mkt. cap
၈၈.၀၈ ကုဋေ
Avg. vol.
၂.၅၇ သိန်း
Volume
၁.၈၆ သိန်း
P/E ratio
၂.၉၄
52-wk high
၅၂.၀၆ US$
52-wk low
၂၄.၉၅ US$
EPS
၁၆.၀၄ US$
Beta
၁.၁၉
Shares outstanding
၁.၈၇ ကုဋေ
No. of employees
၁၇၃
News stories
From web sources and news partners
PR Newswire
PR Newswire
·
ပြီးခဲ့သည့် ၉ နာရီ
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
About Rigel Pharmaceuticals Inc
CEO-
Employees၁၇၃
Founded၁၉၉၆
HeadquartersSouth San Francisco, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiterigel.com
Analyst ratings
Based on 4 analysts giving stock ratings to RIGL in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for RIGL in the last 3 months.
Highest
Current ၄၇.၁၅ US$
၈၅.၀၀ US$ (+၈၀.၂၈%)
Average
၆၅.၀၀ US$ (+၃၇.၈၆%)
Lowest
၄၃.၀၀ US$ (-၈.၈၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
၈၅.၀၀ US$
+၈၀.၃%
09/08/2026
Allison Bratzel
Piper Sandler
Hold
Maintained
၄၉.၀၀ US$
+၃.၉%
08/17/2026
Yigal Nochomovitz
Citi
Buy
Maintained
၈၃.၀၀ US$
+၇၆%
08/06/2026
Kristen Kluska
Cantor Fitzgerald
Hold
Maintained
၄၃.၀၀ US$
-၈.၈%
08/04/2026
Last report
၂၀၂၆ ဩ ၄
Fiscal period
Q2 2026
EPS / Est. (USD)
၀.၈၈ US$ / -၀.၀၈ US$
+၁,၂၆၆.၈၀%beat
Revenue / Est. (USD)
၇.၈၇ ကုဋေ / ၅.၅၃ ကုဋေ
+၄၂.၃၉%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၆.၉၅ ကုဋေ
၆.၉၈ ကုဋေ
၅.၈၈ ကုဋေ
၇.၈၇ ကုဋေ
Cost of goods sold
၁.၂၁ ကုဋေ
၁.၆၆ ကုဋေ
၁.၆၃ ကုဋေ
၂.၂၅ ကုဋေ
Cost of revenue
၁.၂၁ ကုဋေ
၁.၆၆ ကုဋေ
၁.၆၃ ကုဋေ
၂.၂၅ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂.၈၉ ကုဋေ
၃.၀၀ ကုဋေ
၃.၀၇ ကုဋေ
၃.၂၆ ကုဋေ
Operating expense
၂.၈၉ ကုဋေ
၃.၀၀ ကုဋေ
၃.၀၇ ကုဋေ
၃.၂၆ ကုဋေ
Total operating expenses
၄.၁၀ ကုဋေ
၄.၆၆ ကုဋေ
၄.၆၉ ကုဋေ
၅.၅၁ ကုဋေ
Operating income
၂.၈၄ ကုဋေ
၂.၃၂ ကုဋေ
၁.၁၉ ကုဋေ
၂.၃၆ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
၂.၇၆ ကုဋေ
၂.၂၇ ကုဋေ
၁.၁၇ ကုဋေ
၂.၃၆ ကုဋေ
EBT excluding unusual items
၂.၇၆ ကုဋေ
၂.၂၇ ကုဋေ
၁.၁၇ ကုဋေ
၂.၃၆ ကုဋေ
Income tax expense
-၂.၈၀ သိန်း
-၂၄.၅၄ ကုဋေ
၃.၀၀ သန်း
၆.၃၀ သန်း
Effective tax rate
-၁.၀၁%
-၁,၀၈၀.၁၈%
၂၅.၇၆%
၂၆.၆၉%
Other operating expenses
-
-
-
-
Net income
၂.၇၉ ကုဋေ
၂၆.၈၁ ကုဋေ
၈.၆၅ သန်း
၁.၇၃ ကုဋေ
Net profit margin
၄၀.၁၇%
၃၈၄.၀၄%
၁၄.၇၁%
၂၁.၉၇%
Earnings per share
၁.၄၆
၁.၁၂
၀.၄၄
၀.၈၈
Interest and investment income
၁.၀၉ သန်း
၁.၂၄ သန်း
၁.၂၀ သန်း
၇.၈၉ သိန်း
Interest expense
-၁.၈၉ သန်း
-၁.၇၀ သန်း
-၁.၄၃ သန်း
-၇.၇၉ သိန်း
Net interest expenses
-၈.၀၀ သိန်း
-၄.၅၆ သိန်း
-၂.၂၈ သိန်း
၁.၀၀ သောင်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၂.၉၀ ကုဋေ
၂.၃၈ ကုဋေ
၁.၂၅ ကုဋေ
၂.၄၄ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ